Ionis Pharmaceuticals (IONS) Debt Ratio (2009 - 2026)

Ionis Pharmaceuticals' Debt Ratio history runs 18 years deep, the most recent figure standing at 0.13 for Q1 2026.

• On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.13 in Q1 2026; TTM through Mar 2026 was 0.13, a N/A change from a year earlier, with the FY2025 full-year figure at 0.13, up 655.25% from the prior year.
• Debt Ratio eased to 0.13 in Q1 2026 per IONS's latest filing, from 0.13 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.21 in Q2 2025 and bottomed at 0.0 in Q1 2023.
• The 5-year median for Debt Ratio is 0.02 (2024), against an average of 0.06.
• Across the five-year window, Debt Ratio slumped 78.08% in 2022 and surged 1341.29% in 2025, its largest moves.
• Year by year, Debt Ratio stood at 0.01 in 2022, then surged by 357.15% to 0.03 in 2023, then plunged by 40.01% to 0.02 in 2024, then jumped by 655.25% to 0.13 in 2025, then fell by 3.98% to 0.13 in 2026.
• Per Business Quant, the three latest IONS Debt Ratio figures stand at 0.13 (Q1 2026), 0.13 (Q4 2025), and 0.21 (Q3 2025).